Capcold-Plus AF Tablet
By Capcold-Plus AF
Rx
10 Tablet in a Strip

Composition
Cetirizine(5mg) + Paracetamol(325mg) + Phenylephrine(5mg)

Manufacturer - Galpha Laboratories Ltd
Galpha Laboratories Limited, 221, Kanakia Zillion, E Wing, Bandra Kurla Complex Annexe, LBS Marg & CST Road Junction, Kurla West, Mumbai-400070

Expires on or after
August, 2025

liver
Capcold-Plus AF Tablet is considered safe for use in individuals with liver disease, based on the limited available data. It is indicated that adjusting the dosage of Capcold-Plus AF Tablet may not be necessary for patients with liver issues. However, it is crucial to consult your doctor before using this medication to ensure its safe and appropriate use in the context of your liver health.

kidney
Capcold-Plus AF Tablet requires caution in patients with kidney disease. Adjusting the dose may be necessary. Avoid in severe kidney disease; it can induce sleepiness in end-stage kidney disease. Consult your doctor for guidance.

alcohol
It is unsafe to mix alcohol with Capcold-Plus AF Tablet.

driving
Capcold-Plus AF Tablet usually does not impact driving ability.

pregnancy
Capcold-Plus AF Tablet may not be safe during pregnancy. Animal studies suggest potential harm to the baby. Consult your doctor for a careful evaluation of risks and benefits before using this medication during pregnancy.

breastfeeding
Capcold-Plus AF Tablet may be safe during breastfeeding, based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹50.6
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025